Stroke Research and Treatment / 2018 / Article / Tab 2

Clinical Study

Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

Table 2

Primary endpoint occurrences.

ASA n=36controls n=47

n (%)n (%)p-value (Fisher Exact)
New SBIs1 (2.8)6 (12.8)0.103
Stroke1 (2.8)2 (4.3)
TIA-1 (2.1)
No CV events34 (94.4)38 (80.9)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.